# Thyroid Storm

Thyroid storm is a clinical diagnosis of decompensated thyrotoxicosis with acute organ dysfunction. Immediate ICU-level multimodal therapy, treatment of the precipitant, and cautious cardiovascular management are required; thyroid hormone concentrations do not distinguish storm from uncomplicated thyrotoxicosis.[8]

**Clinical question:** How should physicians recognize and immediately manage thyroid storm while minimizing cardiovascular and treatment-related risk?

Updated: 2026-08-20T23:54:25.488837Z

## What matters in practice
- Diagnose thyroid storm clinically from severe thyrotoxicosis plus cardiovascular, CNS, gastrointestinal/hepatic, or thermoregulatory decompensation; FT4 and FT3 concentrations do not reliably separate storm from uncomplicated thyrotoxicosis.[8]
- Do not delay ICU transfer or multimodal treatment for confirmatory laboratory results when the clinical syndrome is convincing.[8]
- Use a thionamide before iodine; administer iodine at least 1 hour later to avoid providing substrate for hormone synthesis, particularly with autonomous nodular disease.[8]
- PTU has theoretical T4-to-T3 conversion benefit, but a multicenter cohort of 1,383 adults found no mortality or adverse-event difference versus methimazole.[1][8]
- Assess for low-output heart failure or cardiogenic shock before beta-blockade. Esmolol permits rapid discontinuation; beta-blockade can precipitate cardiovascular collapse in vulnerable patients.[8][22]

## Recognize thyroid storm as clinical decompensation

Treat suspected storm as an ICU emergency while diagnostic testing proceeds.

Thyroid storm is a life-threatening hypermetabolic state arising from severe thyrotoxicosis and characterized by acute dysfunction of one or more organ systems. Common high-risk findings are hyperthermia, tachyarrhythmia, heart failure or pulmonary edema, CNS disturbance, and gastrointestinal or hepatic dysfunction. Graves disease is the most frequent underlying cause, but toxic nodular disease, amiodarone-induced thyrotoxicosis, thyroiditis, exogenous hormone exposure, and rare hCG-mediated or malignant etiologies can precipitate crisis.[8]

Obtain TSH, free T4, and T3, but do not use hormone magnitude to determine severity or defer treatment. Severe illness may reduce T4-to-T3 conversion, producing a relatively modest or even reference-range T3 despite thyroid storm. Assess end-organ injury and precipitants with ECG, chest imaging when cardiopulmonary involvement is suspected, CBC, metabolic panel, hepatic tests, glucose, lactate, and directed infectious or ischemic evaluation.[8]

Admit to an ICU for continuous cardiac and respiratory monitoring. Mortality estimates vary by case definition and population; reported overall mortality is approximately 5% to 12%, rising to 30% in older adults and those with comorbidity. Cardiogenic shock, multiorgan failure, respiratory failure, arrhythmias, and sepsis are major proximate causes of death.[8]
- Immediately establish airway, oxygenation, circulation, temperature control, IV access, and cardiac monitoring; obtain endocrinology and critical care involvement.[8]
- Actively identify and treat infection, antithyroid-drug discontinuation, surgery or trauma, iodine exposure, acute illness, and other triggers.[8]
- Avoid aspirin for fever because salicylates displace thyroid hormones from binding proteins and may increase free hormone levels; use acetaminophen plus external cooling.[8]

### Clinical scoring supports but does not replace judgment

The Burch-Wartofsky Point Scale incorporates temperature, CNS effects, gastrointestinal/hepatic symptoms, heart rate, heart failure, atrial fibrillation, and a precipitant. A score below 25 makes storm unlikely, 25 to 44 suggests impending storm, and greater than 45 is highly suggestive. Japanese Thyroid Association/Japan Endocrine Society criteria require thyrotoxicosis plus specified combinations of CNS, fever, tachycardia, heart failure, and gastrointestinal/hepatic manifestations. Neither framework should delay treatment of a clinically unstable patient.[8]

*Clinical features that should trigger immediate thyroid-storm treatment and ICU-level care.[8]*

| Domain | Action-relevant findings |
| --- | --- |
| Cardiovascular | Marked tachycardia, atrial fibrillation, pulmonary edema, congestive heart failure, hypotension, or cardiogenic shock.[8] |
| CNS | Agitation, delirium, psychosis, profound lethargy, seizure, or coma.[8] |
| Thermoregulatory | High fever, often greater than 38.5°C; use cooling and acetaminophen rather than aspirin.[8] |
| Gastrointestinal/hepatic | Vomiting, diarrhea, abdominal symptoms, jaundice, or hepatic dysfunction.[8] |
| Context | Known or suspected thyrotoxicosis with infection, medication nonadherence, surgery, trauma, major stress, or iodine exposure.[8] |

## Use concurrent pathway-directed therapy

Treat systemic consequences, hormone production and release, peripheral conversion, and the precipitating disorder simultaneously.

Initial supportive care includes oxygen and ventilatory support as needed, cautious fluid and electrolyte replacement, cooling, acetaminophen, glucose surveillance, and treatment of the precipitating condition. Correct clinically important electrolyte and acid-base disorders and monitor for hypoglycemia, particularly in critically ill patients.[8]

For hyperthyroidism caused by increased hormone synthesis, give a thionamide promptly, followed by iodine after at least 1 hour, glucocorticoid therapy, and appropriately selected rate control. Iodine is not a substitute for thionamide therapy in patients with autonomous nodular disease because it can increase substrate for new hormone synthesis.[8]

Therapy should be tailored to etiology. Thionamides do not block release of preformed hormone in destructive thyroiditis or exogenous thyroid hormone ingestion; management in these settings emphasizes supportive care, beta-blockade when appropriate, glucocorticoids in selected settings, and treatment of the specific cause.[8]

### Block synthesis with PTU or methimazole

PTU is traditionally favored because it also inhibits peripheral T4-to-T3 conversion. A typical regimen is PTU 500 to 1,000 mg orally, by nasogastric tube, or rectally as a loading dose, then 250 mg every 4 hours. Methimazole is an appropriate alternative at 60 to 80 mg/day. In a multicenter observational comparative-effectiveness cohort of 1,383 adults with thyroid storm, PTU and methimazole had no significant differences in mortality or adverse events.[1][8]

Favor methimazole or carbimazole rather than PTU when bilirubin and liver enzymes are at least three times the upper limit of normal, given PTU hepatotoxicity concerns. Intravenous methimazole is not commercially available in the United States; enteral or rectal thionamide administration may be necessary when oral swallowing is not possible.[8]
- Monitor peripheral thyroid hormone concentrations to taper thionamide dosing after clinical stabilization.[8]
- If agranulocytosis or severe thionamide toxicity precludes use, do not simply switch to the alternate thionamide; seek urgent endocrine and surgical input and consider rescue strategies.[8][20]

### Block hormone release after thionamide therapy

At least 1 hour after the thionamide, administer iodine to inhibit hormone synthesis and release. Supported regimens include Lugol iodine 8 drops four times daily, saturated solution of potassium iodide 5 drops four times daily, or potassium iodide 65 mg three times daily. Discontinue iodine once the patient stabilizes, and dilute oral or nasogastric iodine preparations in milk or juice to reduce local irritation.[8]
- Do not administer iodine before thionamide when toxic multinodular goiter or autonomous nodular disease is possible.[8]

### Reduce peripheral conversion and address adrenal reserve

Administer hydrocortisone 300 mg IV as a loading dose followed by 100 mg IV every 8 hours, then taper after clinical improvement. Glucocorticoids reduce peripheral T4-to-T3 conversion and address possible relative or overt adrenal insufficiency in the hypermetabolic state.[8]

### Use beta-blockade selectively and reassess hemodynamics

Propranolol controls adrenergic manifestations and may reduce T4-to-T3 conversion. A guideline-supported oral regimen is 60 to 80 mg every 4 hours; for patients unable to take oral therapy, slow IV propranolol 1 to 3 mg at no more than 1 mg/minute followed, when needed, by infusion at 2 to 3 mg/hour has been described.[8]

Before beta-blockade, assess for low-output heart failure, pulmonary edema, hypotension, shock, or occult thyrotoxic cardiomyopathy. In patients with known or suspected heart failure, use lower initial doses with invasive or close hemodynamic monitoring. Esmolol, with an approximately 9-minute half-life, is often preferred when rapid withdrawal may be needed: 500 mcg/kg IV over 1 minute, then 50 to 100 mcg/kg/minute.[8]

Evidence on propranolol versus beta-1-selective agents is not definitive. A retrospective cohort found similar in-hospital mortality with propranolol and beta-1-selective beta-blockers, including among patients with acute heart failure. Nonetheless, cardiovascular collapse after beta-blockade has been reported, and recent case literature reinforces the need for cautious selection and titration.[8][22]
- If beta-blockers are contraindicated by asthma or cardiac decompensation, diltiazem may be used for rate control.[8]
- Do not interpret persistent tachycardia as an automatic indication for escalating beta-blocker doses without reassessing cardiac output and shock physiology.[8][22]

*Common ICU pharmacotherapy for thyroid storm; regimens and sequencing reflect cited guideline-based review recommendations.[8]*

| Therapeutic target | Preferred options and key safety point |
| --- | --- |
| Adrenergic control | Propranolol 60-80 mg orally every 4 hours; consider esmolol 500 mcg/kg IV over 1 minute then 50-100 mcg/kg/minute when hemodynamic reversibility is important.[8] |
| Inhibit synthesis | PTU 500-1,000 mg load then 250 mg every 4 hours, or methimazole 60-80 mg/day. PTU and methimazole had similar mortality and adverse events in a large observational cohort.[1][8] |
| Inhibit release | After at least 1 hour of thionamide: Lugol iodine 8 drops four times daily, SSKI 5 drops four times daily, or potassium iodide 65 mg three times daily.[8] |
| Reduce conversion/adrenal support | Hydrocortisone 300 mg IV load, then 100 mg IV every 8 hours; taper after improvement.[8] |
| Increase clearance | Cholestyramine 4 g three times daily is an off-label adjunct that interrupts enterohepatic hormone recirculation.[8] |

## Escalate refractory storm and prevent recurrence

Rescue therapies bridge unstable patients to definitive control when conventional treatment fails or is contraindicated.

Consider therapeutic plasma exchange when conventional therapy fails, when thionamides are contraindicated by severe adverse reactions or liver failure, or when rapid preoperative stabilization is required. Plasma exchange transiently lowers circulating thyroid hormones and cytokines; it is a bridge rather than definitive therapy.[3][8]

Emergency thyroidectomy is generally deferred until medical stabilization because operative risk is substantial in uncontrolled thyrotoxicosis. It remains a rare option for refractory storm, severe antithyroid-drug intolerance, or urgent need for definitive hormone control after multidisciplinary assessment.[8]

After recovery, continue antithyroid therapy and arrange definitive treatment planning, typically radioactive iodine or thyroidectomy, to reduce recurrent crisis risk. The appropriate modality depends on the underlying cause and patient factors; long-term management is outside the acute stabilization phase.[8]
- Consider cholestyramine 4 g three times daily as an off-label adjunct when rapid hormone clearance is needed.[8]
- For persistent atrial fibrillation, assess thromboembolic risk and anticoagulation needs using established stroke-risk stratification rather than assuming thyrotoxicosis alone determines the decision.[8]

*Escalation options for refractory thyroid storm.[3][8]*

| Situation | Escalation |
| --- | --- |
| Persistent decompensation despite standard therapy | Therapeutic plasma exchange to transiently remove circulating hormones and cytokines; coordinate with apheresis specialists.[3][8] |
| Thionamide contraindication from severe adverse reaction or liver failure | Plasma exchange as a bridge; pursue urgent definitive management planning.[8] |
| Need for definitive rapid control after unsuccessful medical therapy | Thyroidectomy only in rare, multidisciplinary-selected situations; routine surgery before medical control is not recommended.[8] |

## Modify management for pregnancy, pediatric patients, and cardiac failure

The general sequence remains similar, but drug and monitoring choices require additional caution.

Thyroid storm in pregnancy is rare but carries substantial maternal-fetal risk. Manage in an ICU with continuous cardiac and fetal monitoring and maternal-fetal medicine involvement. Diagnostic scoring systems have not been validated in pregnancy. PTU is preferred for acute storm treatment because of T4-to-T3 conversion inhibition; after stabilization, PTU is generally continued in the first trimester and methimazole is preferred later in pregnancy because of PTU hepatotoxicity and methimazole embryopathy considerations.[23]

In pregnancy, esmolol is favored when beta-blockade is required in a potentially unstable patient because of its short half-life. Propranolol can be used if cardiac dysfunction is considered unlikely, but beta-blockers require caution because pregnant patients may be particularly vulnerable to heart failure and cardiogenic shock. Avoid atenolol because of fetal growth restriction concerns.[23]

Children with thyrotoxicosis should be managed with pediatric endocrinology involvement. Thyroid storm remains a clinical diagnosis; adult scoring systems are not validated in children. Propylthiouracil is generally avoided in children outside exceptional circumstances because of fulminant hepatic failure risk.[5]

*Selected population-specific considerations.[5][23]*

| Population | Decision-critical modification |
| --- | --- |
| Pregnancy | ICU care with fetal monitoring; scoring systems are unvalidated. Use PTU acutely, then reassess trimester-specific antithyroid therapy after stabilization.[23] |
| Pregnancy with uncertain cardiac reserve | Favor titratable esmolol rather than prolonged beta-blockade; avoid atenolol.[23] |
| Children | Prompt pediatric endocrine consultation; adult storm scores are unvalidated and PTU is generally avoided because of fulminant hepatic failure risk.[5] |
| Heart failure or shock | Use cautious, low-dose, titratable beta-blockade with hemodynamic monitoring; evaluate for cardiomyopathy and cardiogenic shock.[8][22] |

## Common questions

### Can thyroid hormone levels confirm or exclude thyroid storm?

No. TSH is usually suppressed and free T4/T3 are elevated, but hormone concentrations overlap substantially with uncomplicated thyrotoxicosis. Diagnose storm from the severity of systemic decompensation and clinical context.[8]

### Should PTU always be preferred over methimazole in thyroid storm?

PTU has an additional peripheral T4-to-T3 conversion effect and remains a traditional initial option, but a large multicenter observational cohort found no significant mortality or adverse-event difference from methimazole. Favor methimazole or carbimazole when significant liver dysfunction is present.[1][8]

### Why must iodine follow a thionamide?

Iodine rapidly inhibits thyroid hormone release, but administered before synthesis blockade it can provide substrate for new hormone production, particularly in autonomous nodular thyroid disease. Give iodine at least 1 hour after a thionamide.[8]

### When should beta-blockers be avoided or modified?

Reassess before use in hypotension, pulmonary edema, suspected low-output heart failure, cardiogenic shock, or thyrotoxic cardiomyopathy. Esmolol offers rapid discontinuation if hemodynamics worsen; diltiazem is an alternative when beta-blockers are contraindicated.[8][22]

### When is plasma exchange appropriate?

Use plasma exchange selectively for refractory storm, contraindication to thionamides from severe toxicity or liver failure, or urgent preoperative stabilization. Its hormone-lowering effect is temporary and should bridge to definitive control.[3][8]

## References
1. Propylthiouracil vs Methimazole for Thyroid Storm in ... — jamanetwork.com — https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2803923
2. THYROTOXIC CRISIS: An Analysis of the Thirty-Six Cases ... — jamanetwork.com — https://jamanetwork.com/journals/jama/fullarticle/294716
3. Thyroid Storm Treatment With Blood Exchange and ... — jamanetwork.com — https://jamanetwork.com/journals/jama/fullarticle/357871
4. Graves' disease - Symptoms, diagnosis and treatment | BMJ Best Practice — bestpractice.bmj.com — https://bestpractice.bmj.com/topics/en-us/32
5. Notes for the general paediatrician: managing thyrotoxicosis in children and young people | BMJ Paediatrics Open — bmjpaedsopen.bmj.com — https://bmjpaedsopen.bmj.com/content/6/1/e001582
6. Hyperthyroidism | Annals of Internal Medicine — annals.org — https://annals.org/aim/article/doi/10.7326/AITC202004070
7. Screening for Thyroid Dysfunction: U.S. Preventive ... — annals.org — https://annals.org/article.aspx?doi=10.7326%2FM15-0483
8. Approach to the patient with thyroid storm — academic.oup.com — https://academic.oup.com/jcem/article/111/5/1484/8467124
9. Perioperative management of the thyrotoxic... : Annals of Medicine & Surgery — journals.lww.com — https://journals.lww.com/annals-of-medicine-and-surgery/fulltext/2022/09000/perioperative_management_of_the_thyrotoxic.160.aspx
10. Prospective Multicenter Registry–Based Study on Thyroid Storm — academic.oup.com — https://academic.oup.com/jcem/article/110/1/e87/7624230
11. Thyroid Storm Precipitated by Fine-needle Aspiration — academic.oup.com — https://academic.oup.com/jcemcr/article/3/9/luaf167/8221508
12. Clinical Features and Hospital Outcomes in Thyroid Storm — academic.oup.com — https://academic.oup.com/jcem/article/100/2/451/2813440
13. Potassium Iodide Use and Patient Outcomes for... : Journal of Clinical Endocrinology & Metabolism — journals.lww.com — https://journals.lww.com/00004678-202502000-00040
14. Risk of perioperative thyroid storm in... : BJA: British Journal of Anaesthesia — journals.lww.com — https://journals.lww.com/00002264-202112000-00011
15. Thyroid Storm in a Toddler Presenting as a Febrile Seizure — publications.aap.org — https://publications.aap.org/pediatrics/article/145/2/e20191920/68249/Thyroid-Storm-in-a-Toddler-Presenting-as-a-Febrile
16. 27: Hyperthyroidism — publications.aap.org — https://publications.aap.org/aapbooks/edited-volume/736/chapter/11706144/Hyperthyroidism
17. Thyroid Emergencies — stacks.cdc.gov — https://stacks.cdc.gov/view/cdc/58372/cdc_58372_DS1.pdf
18. A rare case of thyroid storm - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC4840694
19. Levothyroxine - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/sites/books/NBK539808
20. Antithyroid Drugs — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7393052
21. Levothyroxine - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK539808
22. A Case Report of Thyroid Storm with Cardiovascular Collapse After Propranolol Administration - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC12594221
23. Thyroid storm in pregnancy: a review — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10792856
24. Thyroid Storm - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK448095

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.